Cytos Biotechnology (Monoclonal Antibody Technology Business) Overview

  • Status

  • Acquired/​Merged

  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 1

Cytos Biotechnology (Monoclonal Antibody Technology Business) General Information

Description

Owner an operator of a monoclonal antibodies technology platform. The company is engaged in providing services related to platform technology for the study of antibodies and related researches.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Acquirer
Intercell
Primary Office
  • Wagistrasse 25
  • Postfach
  • 8952 Schlieren
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytos Biotechnology (Monoclonal Antibody Technology Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cytos Biotechnology (Monoclonal Antibody Technology Business)‘s full profile, request access.

Request a free trial

Cytos Biotechnology (Monoclonal Antibody Technology Business) Board Members (1)

Name Representing Role Since
0000 00000000 Self Deputy Chairman 000 0000
To view Cytos Biotechnology (Monoclonal Antibody Technology Business)’s complete board members history, request access »

Cytos Biotechnology (Monoclonal Antibody Technology Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cytos Biotechnology (Monoclonal Antibody Technology Business)‘s full profile, request access.

Request a free trial